Postmenopausal women on the GLP-1 medication tirzepatide (Zepbound) for obesity lost more weight if they were also using ...

Sally Lyons Wyatt, from Data analytics company Circana, says GLP-1 potential users are only three percent more likely to buy ...

Early studies suggest GLP-1 drugs like Ozempic may reduce cravings for alcohol and other addictive substances.

This editorial argues that GLP-1 receptor agonists could substantially improve healthspan and reduce premature mortality in ...

LAS VEGAS -- GLP-1-based therapies may offer benefits in inflammatory bowel disease (IBD) that extend beyond their metabolic indication, according to two poster presentations at the Crohn's & Colitis ...

GLP‑1 weight‑loss drugs are reshaping food industry demand, but side effects, cost barriers and unclear long‑term impacts ...

I’d flirted with my symptoms on and off throughout my life,” one woman told The Post. “But I didn’t have a full-blown relapse ...

CNBC spoke to executives from Eli Lilly, Novo Nordisk, Pfizer and other drugmakers at the annual JPMorgan Healthcare Conference in San Francisco.

A University of Oxford study published in The BMJ finds users of GLP-1 drugs like Ozempic regain weight and reverse heart health improvements within two years of stopping treatment.

According to a November poll from the Kaiser Family Foundation, one in eight Americans reported taking a GLP-1 drug, which ...

Many patients using highly effective GLP-1 drugs like Wegovy may not regain lost weight quickly when they stop treatment, ...

A new study was conducted by Jefferies equity analyst Sheila Kahyaoglu explains how GLP-1 weight loss medications could mean ...